MIRM logo

Mirum Pharmaceuticals, Inc. (MIRM) EBITDA

annual EBITDA:

-$63.98M+$34.35M(+34.93%)
December 31, 2024

Summary

  • As of today (September 16, 2025), MIRM annual EBITDA is -$63.98 million, with the most recent change of +$34.35 million (+34.93%) on December 31, 2024.
  • During the last 3 years, MIRM annual EBITDA has risen by +$108.46 million (+62.90%).
  • MIRM annual EBITDA is now -2094.00% below its all-time high of -$2.92 million, reached on December 31, 2018.

Performance

MIRM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMIRMincome statement metrics

quarterly EBITDA:

$4.19M+$8.19M(+204.65%)
June 30, 2025

Summary

  • As of today (September 16, 2025), MIRM quarterly EBITDA is $4.19 million, with the most recent change of +$8.19 million (+204.65%) on June 30, 2025.
  • Over the past year, MIRM quarterly EBITDA has increased by +$18.77 million (+128.71%).
  • MIRM quarterly EBITDA is now -93.18% below its all-time high of $61.38 million, reached on December 31, 2021.

Performance

MIRM quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMIRMincome statement metrics

TTM EBITDA:

-$18.79M+$18.77M(+49.97%)
June 30, 2025

Summary

  • As of today (September 16, 2025), MIRM TTM EBITDA is -$18.79 million, with the most recent change of +$18.77 million (+49.97%) on June 30, 2025.
  • Over the past year, MIRM TTM EBITDA has increased by +$54.68 million (+74.42%).
  • MIRM TTM EBITDA is now -28810.77% below its all-time high of -$65.00 thousand, reached on September 30, 2018.

Performance

MIRM TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMIRMincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

MIRM EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+34.9%+128.7%+74.4%
3 y3 years+62.9%+114.4%+54.6%
5 y5 years-17.6%+118.1%+75.4%

MIRM EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+62.9%at high+106.1%at high+87.8%
5 y5-year-17.6%+62.9%-93.2%+106.1%at high+88.5%
alltimeall time-2094.0%+62.9%-93.2%+106.1%<-9999.0%+88.5%

MIRM EBITDA History

DateAnnualQuarterlyTTM
Jun 2025
-
$4.19M(-204.7%)
-$18.79M(-50.0%)
Mar 2025
-
-$4.00M(-72.8%)
-$37.56M(-23.3%)
Dec 2024
-$63.98M(-34.9%)
-$14.73M(+246.9%)
-$48.97M(-19.2%)
Sep 2024
-
-$4.25M(-70.9%)
-$60.62M(-17.5%)
Jun 2024
-
-$14.58M(-5.4%)
-$73.47M(-42.4%)
Mar 2024
-
-$15.41M(-41.6%)
-$127.55M(-6.5%)
Dec 2023
-$98.33M(-22.9%)
-$26.38M(+54.2%)
-$136.49M(-3.1%)
Sep 2023
-
-$17.10M(-75.1%)
-$140.84M(-8.8%)
Jun 2023
-
-$68.66M(+182.0%)
-$154.37M(+34.4%)
Mar 2023
-
-$24.35M(-20.8%)
-$114.83M(-6.5%)
Dec 2022
-$127.54M(-26.0%)
-$30.73M(+0.3%)
-$122.85M(+299.6%)
Sep 2022
-
-$30.63M(+5.2%)
-$30.74M(-25.7%)
Jun 2022
-
-$29.12M(-10.1%)
-$41.37M(-19.2%)
Mar 2022
-
-$32.38M(-152.7%)
-$51.18M(-22.2%)
DateAnnualQuarterlyTTM
Dec 2021
-$172.44M(+66.3%)
$61.38M(-248.8%)
-$65.77M(-59.9%)
Sep 2021
-
-$41.25M(+6.0%)
-$163.85M(+13.8%)
Jun 2021
-
-$38.93M(-17.1%)
-$143.95M(+12.4%)
Mar 2021
-
-$46.96M(+28.0%)
-$128.12M(+25.2%)
Dec 2020
-$103.67M(+90.5%)
-$36.70M(+71.9%)
-$102.31M(+24.9%)
Sep 2020
-
-$21.35M(-7.6%)
-$81.93M(+7.3%)
Jun 2020
-
-$23.10M(+9.2%)
-$76.36M(+13.6%)
Mar 2020
-
-$21.15M(+29.5%)
-$67.20M(+28.7%)
Dec 2019
-$54.42M(+1766.2%)
-$16.33M(+3.5%)
-$52.21M(+45.5%)
Sep 2019
-
-$15.78M(+13.1%)
-$35.88M(+77.9%)
Jun 2019
-
-$13.95M(+126.5%)
-$20.17M(+224.1%)
Mar 2019
-
-$6.16M(+9372.3%)
-$6.22M(+9472.3%)
Dec 2018
-$2.92M
-
-
Sep 2018
-
-$65.00K
-$65.00K

FAQ

  • What is Mirum Pharmaceuticals, Inc. annual EBITDA?
  • What is the all time high annual EBITDA for Mirum Pharmaceuticals, Inc.?
  • What is Mirum Pharmaceuticals, Inc. annual EBITDA year-on-year change?
  • What is Mirum Pharmaceuticals, Inc. quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Mirum Pharmaceuticals, Inc.?
  • What is Mirum Pharmaceuticals, Inc. quarterly EBITDA year-on-year change?
  • What is Mirum Pharmaceuticals, Inc. TTM EBITDA?
  • What is the all time high TTM EBITDA for Mirum Pharmaceuticals, Inc.?
  • What is Mirum Pharmaceuticals, Inc. TTM EBITDA year-on-year change?

What is Mirum Pharmaceuticals, Inc. annual EBITDA?

The current annual EBITDA of MIRM is -$63.98M

What is the all time high annual EBITDA for Mirum Pharmaceuticals, Inc.?

Mirum Pharmaceuticals, Inc. all-time high annual EBITDA is -$2.92M

What is Mirum Pharmaceuticals, Inc. annual EBITDA year-on-year change?

Over the past year, MIRM annual EBITDA has changed by +$34.35M (+34.93%)

What is Mirum Pharmaceuticals, Inc. quarterly EBITDA?

The current quarterly EBITDA of MIRM is $4.19M

What is the all time high quarterly EBITDA for Mirum Pharmaceuticals, Inc.?

Mirum Pharmaceuticals, Inc. all-time high quarterly EBITDA is $61.38M

What is Mirum Pharmaceuticals, Inc. quarterly EBITDA year-on-year change?

Over the past year, MIRM quarterly EBITDA has changed by +$18.77M (+128.71%)

What is Mirum Pharmaceuticals, Inc. TTM EBITDA?

The current TTM EBITDA of MIRM is -$18.79M

What is the all time high TTM EBITDA for Mirum Pharmaceuticals, Inc.?

Mirum Pharmaceuticals, Inc. all-time high TTM EBITDA is -$65.00K

What is Mirum Pharmaceuticals, Inc. TTM EBITDA year-on-year change?

Over the past year, MIRM TTM EBITDA has changed by +$54.68M (+74.42%)
On this page